Rosenberger, Carrie M.
Wick, Katherine D.
Zhuo, Hanjing
Wu, Nelson
Chen, Yue
Kapadia, Sharookh B.
Guimaraes, Alessander
Chang, Diana
Choy, David F.
Chen, Hubert
Peck, Melicent
Sullivan, Kathryn M.
Ke, Serena
Jauregui, Alejandra
Leligdowicz, Aleksandra
Sinha, Pratik
Gomez, Antonio D.
Kangelaris, Kirsten N.
Delucchi, Kevin
Liu, Kathleen D.
Calfee, Carolyn S.
Matthay, Michael A.
Hendrickson, Carolyn M.
Funding for this research was provided by:
Genentech, Inc
National Institutes of Health (R35HL140026, R35HL140026, R35HL140026, R35HL140026)
Article History
Received: 29 March 2023
Accepted: 6 June 2023
First Online: 13 June 2023
Declarations
:
: The study was carried out in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of the University of California, San Francisco. Subjects or a designated surrogate provided informed consent for study participation unless the subject died before their surrogate could be approached for informed consent or the subject was too ill to provide consent and a surrogate could not be identified within 28 days. In these cases, the IRB approved a waiver of consent.
: Not applicable.
: YC, KD, ADG, AJ, KNK, SK, AL, KMS, KDW, NW, and HZ declare that they have no competing interests. DC, HC, DFC, AG, SBK, MP, and CMR were employed by Genentech and owned Roche stock at the time of the study. CSC declares grants and personal fees from Roche/Genentech, grants and personal fees from Bayer, personal fees from Gen1e Life Sciences, personal fees from Vasomune, grants from Quantum Leap Healthcare Collaborative, personal fees from Janssen, personal fees from Cellenkos, and personal fees from NGM Bio. CMH received consultancy fees from Spring Discovery. KDL declares consultancy agreements with AM Pharma, Biomerieux, BOA Medical, Neumora, and Seastar Medical; stock in Amgen; serving on the Editorial Boards of American Journal of Kidney Diseases, American Journal of Respiratory and Critical Care Medicine, and CJASN; advisory or leadership roles for the American Thoracic Society and NKF Scientific Advisory Board; and other interests or relationships with UpToDate. MAM declares a research grant paid to UCSF from Genentech-Roche and consulting income from Johnson & Johnson, Novartis, Pliant Therapeutics, Quantum Health, and Gilead. PS declares Personal fees from Astra-Zeneca.